Evidence for metabolic and reproductive phenotypes in mothers of women with polycystic ovary syndrome. - Wikidata - wikimedia - TriplyDB

Evidence for metabolic and reproductive phenotypes in mothers of women with polycystic ovary syndrome.

Evidence for metabolic and reproductive phenotypes in mothers of women with polycystic ovary syndrome.

http://www.wikidata.org/entity/Q34598493

about

Polycystic ovary syndrome: a complex condition with psychological, reproductive and metabolic manifestations that impacts on health across the lifespan Dyslipidemia in women with polycystic ovary syndrome Scientific Statement on the Diagnostic Criteria, Epidemiology, Pathophysiology, and Molecular Genetics of Polycystic Ovary Syndrome.Evidence for gonadotrophin secretory and steroidogenic abnormalities in brothers of women with polycystic ovary syndrome Parent-of-origin effects on glucose homeostasis in polycystic ovary syndrome.Intergenerational associations of chronic disease and polycystic ovary syndrome Insulin resistance and the polycystic ovary syndrome revisited: an update on mechanisms and implications.Diagnosis and treatment of polycystic ovary syndrome: an Endocrine Society clinical practice guideline Associations of birthweight and gestational age with reproductive and metabolic phenotypes in women with polycystic ovarian syndrome and their first-degree relatives.Prevalence of metabolic syndrome in the family members of women with polycystic ovary syndrome from North India.Metabolic phenotype in the brothers of women with polycystic ovary syndrome.The role of the polycystic ovary syndrome susceptibility locus D19S884 allele 8 in maternal glycemia and fetal size Developmental programming: insulin sensitizer treatment improves reproductive function in prenatal testosterone-treated female sheep The American Diabetes Association's 57th annual advanced postgraduate course: diabetes risk, vitamin D, polycystic ovary syndrome, and obstructive sleep apnea.Prenatal androgen treatment alters body composition and glucose homeostasis in male rats Family association study between INSR gene polymorphisms and PCOS in Han Chinese.Evidence for increased cardiovascular events in the fathers but not mothers of women with polycystic ovary syndrome Birth weight and childhood growth in daughters of women with irregular menstrual cycles.Diagnosis and treatment of polycystic ovary syndrome (PCOS): an interview with Richard Legro.State of the Art Review: Emerging Therapies: The Use of Insulin Sensitizers in the Treatment of Adolescents with Polycystic Ovary Syndrome (PCOS).Paternal history of diabetes mellitus and hypertension affects the prevalence and phenotype of PCOS.Replication of association of DENND1A and THADA variants with polycystic ovary syndrome in European cohorts Familial aggregation of circulating C-reactive protein in polycystic ovary syndrome Contemporary medical therapy for polycystic ovary syndrome.Hyperandrogenism and hyperinsulinism in children of women with polycystic ovary syndrome: a controlled study Perspectives in Polycystic Ovary Syndrome: From Hair to Eternity Targets to treat metabolic syndrome in polycystic ovary syndrome Risk of cardiovascular events in mothers of women with polycystic ovary syndrome.Searching for polycystic ovary syndrome in postmenopausal women: evidence of a dose-effect association with prevalent cardiovascular disease The role of genetic variation in the lamin a/c gene in the etiology of polycystic ovary syndrome.Evidence for association between polycystic ovary syndrome (PCOS) and TCF7L2 and glucose intolerance in women with PCOS and TCF7L2.Metabolic features of the reproductive phenotypes of polycystic ovary syndrome.High prevalence of metabolic syndrome in first-degree male relatives of women with polycystic ovary syndrome is related to high rates of obesity.Variation in the perilipin gene (PLIN) affects glucose and lipid metabolism in non-Hispanic white women with and without polycystic ovary syndrome.Excess mortality in mothers of patients with polycystic ovary syndrome.The Pathogenesis of Polycystic Ovary Syndrome (PCOS): The Hypothesis of PCOS as Functional Ovarian Hyperandrogenism Revisited.Metabolic syndrome, hypertension, and hyperlipidemia in mothers, fathers, sisters, and brothers of women with polycystic ovary syndrome: a systematic review and meta-analysis.Cardiometabolic Risk in PCOS: More than a Reproductive Disorder.Computational characterization and identification of human polycystic ovary syndrome genes Hyperinsulinaemic androgen excess in adolescent girls

P2860

Q21245262-F702BCF1-048B-4586-B76C-9ECF2C62FB86 Q27025695-1DD67883-C8DE-43B9-B7C8-6B3FCA7AE95F Q28390200-BD5173C1-66E8-4AA7-9554-5926C3FFA385 Q30303066-376C0276-74C0-4C99-AB84-6B043801D53A Q30371644-EB18BE75-8502-4CC3-8744-A255237352CD Q31032859-764D84BC-BD84-4EE2-BE89-0F6F9285225A Q33569169-2C9E0DCD-A8FE-46DF-9CCB-D6CDD5C866D3 Q33587845-8F8FB385-31F2-4FD8-8B68-699D2A46C154 Q33736117-E9D9632C-0F78-4C14-A99F-F40040AD55E1 Q33750469-AD319B6F-BAE9-4522-920D-DA200AB0FD89 Q33962557-EDC5BFAC-B0C2-47AA-8905-C1D877ABE9F8 Q34086652-FEC118C4-E3C4-45B0-99E9-156540FB84C1 Q34132558-D9594D8E-0819-483E-80B6-6733B80E2427 Q34421903-1ED436D0-8FF8-4F5B-BEA7-06A8FB851E62 Q34574446-DA5AA3A8-C6BF-4379-8415-9C9E9697B337 Q35054114-0FCD3E3F-AC09-4BF1-94E9-1B6491AE2252 Q35108260-2F3E9181-FFC2-4A2A-ABB5-A72377D5130D Q35137230-29381586-161D-4174-843D-D8E61A51F228 Q35222436-3BEBE960-F0BA-4931-A668-8ADDCBA1D583 Q35233754-280F7DAC-9D26-4E62-9EC2-72EF01FBF55F Q36378517-B5EFE0DF-5130-4153-B17D-660D304F7F8C Q36507128-53BAFAE7-031C-4724-A188-EA8B0FC62D9A Q36607455-3EC4A7A2-E08D-48EF-80E8-0EF7C212AB72 Q36608161-4E572C10-9534-445F-8BC1-58BF737151C6 Q36661975-3A07348D-F7FB-4D83-B313-54A5D7F3CBAC Q36716040-D58E3696-196C-459A-B56B-DBA875DA6719 Q36943683-0F6BAF08-6344-4A9F-B9CF-1BE927B9B86D Q37091345-3FA28BBE-29E1-4395-93B9-82657910B852 Q37097161-674BAD92-08BF-45AD-9B2F-32FBC16D8D32 Q37257568-7E909289-8C07-4799-A9AD-7B96952100A0 Q37257592-5974A5FD-0AC2-4A3C-B080-004FED8EE314 Q37412812-2CAFFBEE-85A5-44FA-8D59-1A79E705BEA1 Q37417433-137AF6CB-4FC0-4690-97BC-F537E8B369EE Q37478028-A49358F4-3B8B-4C82-AA26-1BAA59BFDA67 Q38420503-0D435254-FE7C-4C31-9790-168A9C89B041 Q41640666-B729C7AF-FB3A-4823-8B05-26B0ED52CAF2 Q50056205-9AEA01D8-61A9-490A-8DD0-169803C5A5CB Q50056959-BC38CF2C-DEA2-424F-AF00-E470EB54DA0B Q58699715-474B627D-B501-42C4-8045-498B88412B79 Q58811102-969F8823-4415-42B1-8AC2-EC96BE2B5FA3

P2860

Evidence for metabolic and reproductive phenotypes in mothers of women with polycystic ovary syndrome.

http://www.wikidata.org/entity/Q34598493

description

2006 nî lūn-bûn

@nan

2006 թուականի Ապրիլին հրատարակուած գիտական յօդուած

@hyw

2006 թվականի ապրիլին հրատարակված գիտական հոդված

@hy

2006年の論文

@ja

2006年学术文章

@wuu

2006年学术文章

@zh-cn

2006年学术文章

@zh-hans

2006年学术文章

@zh-my

2006年学术文章

@zh-sg

2006年學術文章

@yue

name

Evidence for metabolic and rep ...... ith polycystic ovary syndrome.

@ast

Evidence for metabolic and rep ...... ith polycystic ovary syndrome.

@en

Evidence for metabolic and rep ...... ith polycystic ovary syndrome.

@nl

type

label

Evidence for metabolic and rep ...... ith polycystic ovary syndrome.

@ast

Evidence for metabolic and rep ...... ith polycystic ovary syndrome.

@en

Evidence for metabolic and rep ...... ith polycystic ovary syndrome.

@nl

prefLabel

Evidence for metabolic and rep ...... ith polycystic ovary syndrome.

@ast

Evidence for metabolic and rep ...... ith polycystic ovary syndrome.

@en

Evidence for metabolic and rep ...... ith polycystic ovary syndrome.

@nl

P1433

Q34598493-81D05225-A27D-4C98-889A-37B3A4FB2979

P1476

Q34598493-61DBFD05-E5B3-4C54-9672-11A1ED0C5695

P2093

Q34598493-02A8F0D1-DFAF-4463-ABD0-BD2A445AB343

Q34598493-1ABCBA85-2DA6-4E6B-9224-C7F73E2ED173

Q34598493-B09D11B3-CD81-4F85-A367-710E50881D0A

Q34598493-B21AC516-1595-49CE-AB58-2269B6BED0C2

Q34598493-B24EB3D3-BE42-415A-89D8-700EBD9D3469

P2860

Q34598493-0376704E-E136-45DB-83A2-C04667E05A5E

Q34598493-0BA74C5A-5515-461A-AB6D-6C984CF11B85

Q34598493-0E542188-1798-48F2-8C6F-E2BA53C7F953

Q34598493-10B5B26C-13B7-407B-A4F6-E296853DDE45

Q34598493-1D60D35E-710A-427A-BED8-C5C0335FAF07

Q34598493-2EBB8D23-B2FA-46E7-A472-023F2324D443

Q34598493-2F484590-DE08-4437-8896-0D2D695EE5A1

Q34598493-44ABA608-DA8C-4DA1-BA4B-51384BF5EDAC

Q34598493-44FED281-082E-4B07-A962-FE87B83979F4

Q34598493-46C647FD-7BBE-409E-A3BF-60B36372DD77

P304

Q34598493-784CEAC7-B1AD-41A9-8805-0A1E22249E42

P31

Q34598493-64B9DB98-2CDA-43BB-981E-902E98356595

P356

Q34598493-CF72B2C4-4B42-4A9F-897A-AC0F4A01C5E3

P407

Q34598493-3E13A2BD-C0DC-4FB6-8B97-F4D7F58675A4

P433

Q34598493-782DF05A-E55D-42FE-A0FF-75C9B6F4E223

P478

Q34598493-16CC7E11-DFF5-49DA-89CA-45FE8A7AC224

P577

Q34598493-3882DF55-1232-405F-996F-B8A71FCFA95E

P5875

Q34598493-E67EBF2C-5C80-404F-98C7-449935D55B22

P698

Q34598493-41E17375-4C4D-4980-9D1E-E80528192E4D

P921

Q34598493-3817A8D3-87BD-4107-B4C2-930A3E8781FB

P932

Q34598493-7E1C32AB-D157-4364-A706-7482B3A5D47F

P356

PNAS.0602025103

P1433

Proceedings of the National Academy of Sciences of the United States of America

P1476

Evidence for metabolic and rep ...... ith polycystic ovary syndrome.

@en

P2093

Andrea Dunaif

http://www.w3.org/2001/XMLSchema#string

Paulina A Essah

http://www.w3.org/2001/XMLSchema#string

Richard S Legro

http://www.w3.org/2001/XMLSchema#string

Susan Sam

http://www.w3.org/2001/XMLSchema#string

Teimuraz Apridonidze

http://www.w3.org/2001/XMLSchema#string

P2860

Homeostasis model assessment: insulin resistance and ?-cell function from fasting plasma glucose and insulin concentrations in man

Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III)

Association of the steroid synthesis gene CYP11a with polycystic ovary syndrome and hyperandrogenism

Predicting impaired glucose tolerance using common clinical information: data from the Third National Health and Nutrition Examination Survey.

Prevalence of polycystic ovary syndrome (PCOS) in first-degree relatives of patients with PCOS.

Insulin-lowering medications in polycystic ovary syndrome.

Prevalence of polycystic ovaries in women with anovulation and idiopathic hirsutism

The prevalence and features of the polycystic ovary syndrome in an unselected population.

Bias due to misclassification in the estimation of relative risk.

Prevalence and predictors of risk for type 2 diabetes mellitus and impaired glucose tolerance in polycystic ovary syndrome: a prospective, controlled study in 254 affected women.

P304

7030-7035

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1073/PNAS.0602025103

http://www.w3.org/2001/XMLSchema#string

P407

P433

18

http://www.w3.org/2001/XMLSchema#string

P478

103

http://www.w3.org/2001/XMLSchema#string

P577

2006-04-21T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

7147406

http://www.w3.org/2001/XMLSchema#string

P698

16632599

http://www.w3.org/2001/XMLSchema#string

P921

polycystic ovary syndrome

P932

1459013

http://www.w3.org/2001/XMLSchema#string